vs
Side-by-side financial comparison of DESCARTES SYSTEMS GROUP INC (DSGX) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $179.8M, roughly 1.2× DESCARTES SYSTEMS GROUP INC). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 21.1%, a 36.2% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $62.1M).
The Descartes Systems Group Inc. is a Canadian multinational technology company specializing in logistics software, supply chain management software, and cloud-based services for logistics businesses.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
DSGX vs IDYA — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $179.8M | $207.8M |
| Net Profit | $38.0M | $119.2M |
| Gross Margin | 76.9% | — |
| Operating Margin | 26.8% | 52.2% |
| Net Margin | 21.1% | 57.4% |
| Revenue YoY | — | — |
| Net Profit YoY | — | 330.1% |
| EPS (diluted) | $0.43 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $179.8M | $207.8M | ||
| Q3 24 | $163.4M | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 | ||
| Q3 23 | $143.4M | — | ||
| Q3 22 | $123.0M | $29.7M |
| Q3 25 | $38.0M | $119.2M | ||
| Q3 24 | $34.7M | $-51.8M | ||
| Q2 24 | — | $-52.8M | ||
| Q1 24 | — | $-39.6M | ||
| Q3 23 | $28.1M | — | ||
| Q3 22 | $22.9M | $1.6M |
| Q3 25 | 76.9% | — | ||
| Q3 24 | 75.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | 75.6% | — | ||
| Q3 22 | 76.5% | — |
| Q3 25 | 26.8% | 52.2% | ||
| Q3 24 | 28.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | 25.7% | — | ||
| Q3 22 | 25.6% | 2.2% |
| Q3 25 | 21.1% | 57.4% | ||
| Q3 24 | 21.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | 19.6% | — | ||
| Q3 22 | 18.6% | 5.4% |
| Q3 25 | $0.43 | $1.33 | ||
| Q3 24 | $0.40 | $-0.60 | ||
| Q2 24 | — | $-0.68 | ||
| Q1 24 | — | $-0.53 | ||
| Q3 23 | $0.32 | — | ||
| Q3 22 | $0.27 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $240.6M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $1.1B |
| Total Assets | $1.8B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $240.6M | $786.9M | ||
| Q3 24 | $252.7M | $920.0M | ||
| Q2 24 | — | $701.7M | ||
| Q1 24 | — | $698.8M | ||
| Q3 23 | $227.4M | — | ||
| Q3 22 | $189.0M | $386.2M |
| Q3 25 | $1.5B | $1.1B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | — | $931.7M | ||
| Q1 24 | — | $935.3M | ||
| Q3 23 | $1.2B | — | ||
| Q3 22 | $1.0B | $368.8M |
| Q3 25 | $1.8B | $1.2B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | — | $973.7M | ||
| Q1 24 | — | $961.5M | ||
| Q3 23 | $1.4B | — | ||
| Q3 22 | $1.2B | $410.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.3M | $142.2M |
| Free Cash FlowOCF − Capex | $62.1M | $142.2M |
| FCF MarginFCF / Revenue | 34.5% | 68.4% |
| Capex IntensityCapex / Revenue | 0.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.67× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $189.6M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $63.3M | $142.2M | ||
| Q3 24 | $34.7M | $-49.2M | ||
| Q2 24 | — | $-32.9M | ||
| Q1 24 | — | $-43.8M | ||
| Q3 23 | $52.0M | — | ||
| Q3 22 | $46.4M | $-24.2M |
| Q3 25 | $62.1M | $142.2M | ||
| Q3 24 | $33.1M | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M | ||
| Q3 23 | $49.8M | — | ||
| Q3 22 | $44.6M | $-25.3M |
| Q3 25 | 34.5% | 68.4% | ||
| Q3 24 | 20.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | 34.8% | — | ||
| Q3 22 | 36.3% | -85.1% |
| Q3 25 | 0.7% | 0.0% | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | 1.5% | — | ||
| Q3 22 | 1.5% | 3.7% |
| Q3 25 | 1.67× | 1.19× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | 1.85× | — | ||
| Q3 22 | 2.03× | -14.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
